Marker for determination of sensitivity to triplet combination anti-cancer agent

• 收藏
• 分享

专利权人:

Kabushiki Kaisha Yakult Honsha

发明人:

Nishiyama, Masahiko,Eguchi, Hidetaka,Wada, Satoru

申请号：

AU2011337612

公开号：

AU2011337612B2

申请日:

2011.12.02

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

Provided are: a marker for determining the sensitivity to an anti-cancer agent, which can determine the therapeutic reactivity of individual patients； and a novel cancer therapy means which utilizes the marker.A marker for determining the sensitivity to an anti-cancer agent, which comprises at least one gene selected from ALAD gene, C20orf43 gene, CABLES1 gene, CDC14B gene, GDA gene, HOXB6 gene, RPL7AP27 gene, TMEM18 gene and UGT2B10 gene and contains oxaliplatin or a salt thereof, fluorouracil or a salt thereof and levofolinate or a salt thereof.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/